26106364|t|Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding.
26106364|a|Human dopamine (DA) transporter (hDAT) regulates dopaminergic signaling in the central nervous system by maintaining the synaptic concentration of DA at physiological levels, upon reuptake of DA into presynaptic terminals. DA translocation involves the co-transport of two sodium ions and the channeling of a chloride ion, and it is achieved via alternating access between outward-facing (OF) and inward-facing states of DAT. hDAT is a target for addictive drugs, such as cocaine, amphetamine (AMPH), and therapeutic antidepressants. Our recent quantitative systems pharmacology study suggested that orphenadrine (ORPH), an anticholinergic agent and anti-Parkinson drug, might be repurposable as a DAT drug. Previous studies have shown that DAT-substrates like AMPH or -blockers like cocaine modulate the function of DAT in different ways. However, the molecular mechanisms of modulation remained elusive due to the lack of structural data on DAT. The newly resolved DAT structure from Drosophila melanogaster opens the way to a deeper understanding of the mechanism and time evolution of DAT-drug/ligand interactions. Using a combination of homology modeling, docking analysis, molecular dynamics simulations, and molecular biology experiments, we performed a comparative study of the binding properties of DA, AMPH, ORPH, and cocaine and their modulation of hDAT function. Simulations demonstrate that binding DA or AMPH drives a structural transition toward a functional form predisposed to translocate the ligand. In contrast, ORPH appears to inhibit DAT function by arresting it in the OF open conformation. The analysis shows that cocaine and ORPH competitively bind DAT, with the binding pose and affinity dependent on the conformational state of DAT. Further assays show that the effect of ORPH on DAT uptake and endocytosis is comparable to that of cocaine. 
26106364	32	52	Dopamine Transporter	Gene	6531
26106364	65	76	Amphetamine	Chemical	MESH:D000661
26106364	78	90	Orphenadrine	Chemical	MESH:D009966
26106364	96	103	Cocaine	Chemical	MESH:D003042
26106364	113	118	Human	Species	9606
26106364	119	144	dopamine (DA) transporter	Gene	6531
26106364	386	392	sodium	Chemical	MESH:D012964
26106364	422	430	chloride	Chemical	MESH:D002712
26106364	534	537	DAT	Gene	6531
26106364	560	575	addictive drugs	Chemical	-
26106364	585	592	cocaine	Chemical	MESH:D003042
26106364	594	605	amphetamine	Chemical	MESH:D000661
26106364	607	611	AMPH	Chemical	MESH:D000661
26106364	713	725	orphenadrine	Chemical	MESH:D009966
26106364	727	731	ORPH	Chemical	MESH:D009966
26106364	768	777	Parkinson	Disease	MESH:D010302
26106364	811	814	DAT	Gene	6531
26106364	854	857	DAT	Gene	6531
26106364	874	878	AMPH	Chemical	MESH:D000661
26106364	897	904	cocaine	Chemical	MESH:D003042
26106364	930	933	DAT	Gene	6531
26106364	1056	1059	DAT	Gene	6531
26106364	1080	1083	DAT	Gene	36849
26106364	1099	1122	Drosophila melanogaster	Species	7227
26106364	1202	1205	DAT	Gene	6531
26106364	1425	1429	AMPH	Chemical	MESH:D000661
26106364	1431	1435	ORPH	Chemical	MESH:D009966
26106364	1441	1448	cocaine	Chemical	MESH:D003042
26106364	1531	1535	AMPH	Chemical	MESH:D000661
26106364	1644	1648	ORPH	Chemical	MESH:D009966
26106364	1668	1671	DAT	Gene	6531
26106364	1750	1757	cocaine	Chemical	MESH:D003042
26106364	1762	1766	ORPH	Chemical	MESH:D009966
26106364	1786	1789	DAT	Gene	6531
26106364	1867	1870	DAT	Gene	6531
26106364	1911	1915	ORPH	Chemical	MESH:D009966
26106364	1919	1922	DAT	Gene	6531
26106364	1971	1978	cocaine	Chemical	MESH:D003042
26106364	Negative_Correlation	MESH:D003042	6531
26106364	Negative_Correlation	MESH:D009966	6531
26106364	Comparison	MESH:D003042	MESH:D009966
26106364	Negative_Correlation	MESH:D009966	MESH:D010302
26106364	Positive_Correlation	MESH:D000661	6531

